Detalhe da pesquisa
1.
The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK.
Int J Cancer
; 2024 Apr 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38685816
2.
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.
Eur J Nucl Med Mol Imaging
; 49(1): 371-384, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33837843
3.
Real-world use of bevacizumab in metastatic colorectal, metastatic breast, advanced ovarian and cervical cancer: a systematic literature review.
Future Oncol
; 15(5): 543-561, 2019 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30379088
4.
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 19(4): 562-578, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29611518
5.
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.
Br J Cancer
; 119(11): 1332-1338, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30420616
6.
Correction to: FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.
Eur J Nucl Med Mol Imaging
; 49(2): 786-787, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34894284
7.
Initiation of Cancer: The Journey From Mutations in Somatic Cells to Epigenetic Changes in Tissue-resident VSELs.
Stem Cell Rev Rep
; 20(4): 857-880, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38457060
8.
SCOT: Tumor Sidedness and the Influence of Adjuvant Chemotherapy Duration on Disease Free Survival (DFS).
Clin Colorectal Cancer
; 22(2): 231-237, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36967267
9.
Clinical and Regulatory Considerations for the Use of Bevacizumab Biosimilars in Metastatic Colorectal Cancer.
Clin Colorectal Cancer
; 20(1): 42-51.e3, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33243618
10.
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors.
Clin Colorectal Cancer
; 20(4): 342-349, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34696965
11.
Encephalopathy secondary to capecitabine chemotherapy: a case report and discussion.
J Oncol Pharm Pract
; 15(4): 237-9, 2009 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-19276137
12.
ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UK.
Clin Colorectal Cancer
; 18(4): 280-291.e5, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31451367
13.
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Health Technol Assess
; 23(64): 1-88, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31852579
14.
Use of bevacizumab in the treatment of metastatic colorectal cancer.
Br J Hosp Med (Lond)
; 73(1): 25-30, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22241406